Stay updated with breaking news from Affinity Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today bioAffinity Technologies,...
/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bio-Affinity...
Six small deals priced this past week, though only three met the criteria for our 2022 IPO stats.
BioAffinity Technologies, Inc. (BIAF) plans to raise $10 million in an IPO on Tuesday, May 31st, IPO Scoop reports. The company will be issuing 1,500,000 shares at a price of $6.75 per share. WallachBeth Capital acted as the underwriter for the IPO. bioAffinity Technologies, Inc. provided the following description of their company for its IPO: […]
BioAffinity Technologies has filed to raise capital via a U.S. IPO. The firm is developing a lung cancer detection test. Read what to know about the IPO here.